TITLE

FDA approves first single-lead ICD with atrial sensing

PUB. DATE
March 2013
SOURCE
British Journal of Hospital Medicine (17508460);Mar2013, Vol. 74 Issue 3, p129
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article states that U.S. federal agency Food and Drug Administration (FDA) has approved a first-in-class implantable cardiac defibrillator (ICD) Biotronik Lumax 740 DX System.
ACCESSION #
86431982

 

Related Articles

  • Subcutaneous ICD system wins FDA approval.  // Cardiology Today;Nov2012, Vol. 15 Issue 11, p1 

    The article reports that the U.S. Food and Drug Administration (FDA) approved the use of subcutaneous implantable cardioverter defibrillator system.

  • Biotronik receives FDA nod for Lumax 740 DX System. FORD, OMAR // Medical Device Daily;2/28/2013, Vol. 17 Issue 40, p1 

    The article reports on the approval of the U.S. Food and Drug Administration (FDA) for the Biotronik Lumax 740 DX System from Berlin, Germany-based biomedical technology company Biotronik SE & Co. KG. It notes that Lumax 740 is an implantable cardiac defibrillator (ICD) device that utilizes...

  • Concerns voiced over FDA premarket testing of ICD connector systems. Raible, Eric // Cardiology Today;Jan2009, Vol. 12 Issue 1, p15 

    The article reports that the impending rollout of an implantable cardioverter defibrillator (ICD) technology has prompted concern from some practitioners regarding the U.S. Food and Drug Administration's (FDA) premarket testing of the technologies.

  • FDA Expands Use of Implanted Defibrillators.  // Medical Update;2002, Vol. 28 Issue 2, p4 

    Focuses on a ruling by the U.S. Food and Drug Administration that would raise the number of people who could benefit from implantable cardioverter defibrillators.

  • Is Biology Destiny or Can We Optimize Care for All Patients? Douglas, Pamela S.; Curtis, Lesley H. // Annals of Internal Medicine;2/7/2012, Vol. 156 Issue 3, p241 

    The author presents his views on the experience of implantable cardioverter-defibrillators (ICDs). He states that the complication rates of biological differences are found more in women. He thinks that exploring the differences of men and women will help in deep understanding of...

  • FDA okays St. Jude's Promote Plus CRT-D, Current Plus ICD. PEDERSEN, AMANDA // Diagnostics & Imaging Week;5/14/2009, Vol. 12 Issue 19, p2 

    The article reports on an approval received by St. Jude Medical from the U.S. Food and Drug Administration (FDA) for the Promote Plus cardiac resynchronization therapy defibrillator (CRT-D) and Current Plus implantable cardioverter defibrillators (ICD). The medical products were designed with...

  • Miniature, dual-chamber implantable defibrillation approved.  // Healthcare Purchasing News;Feb2001, Vol. 25 Issue 2, p6 

    Announces that the U.S. Food and Drug Administration approve the implantable cardioverter defibrillator system from Guidant Corp. Purpose of the device; Symptoms experienced by patients with fast heart rhythms.

  • FDA approves new ICD and pacemaker platform.  // Healthcare Purchasing News;Feb2001, Vol. 25 Issue 2, p15 

    Announces that the U.S. Food and Drug Administration granted pre-market approval to ELA Medical's implantable cardioverter defibrillator and peacemaker programming platform in February 2001. Software to be launched by the company.

  • Editor's note.  // New England Journal of Medicine;6/1/2006, Vol. 354 Issue 22, p2312 

    The article ponders on life-threatening malfunctions of implantable cardiac devices. It highlights the action taken by Guidant Communications to address the malfunctions of its implantable defibrillators. It emphasizes the cardiac-device industry's need for physicians with defined...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics